Phoenix: A Portable, Battery-Powered, and Environmentally Controlled Platform for Long-Distance Transportation of Live-Cell Cultures

Frontiers in Bioengineering and Biotechnology
Brittany N WillbrandDevin M Ridgley

Abstract

Despite the advent of advanced therapy medicinal products (ATMPs) in regenerative medicine, gene therapy, cell therapies, tissue engineering, and immunotherapy, the availability of treatment is limited to patients close to state-of-the-art facilities. The SCORPIO-V Division of HNu Photonics has developed the Phoenix-Live Cell TransportTM, a battery-operated mobile incubator designed to facilitate long-distance transportation of living cell cultures from GMP facilities to remote areas for increased patient accessibility to ATMPs. This work demonstrates that PhoenixTM (patent pending) is a superior mechanism for transporting living cells compared to the standard method of shipping frozen cells on dry ice (-80°C) or in liquid nitrogen (-150°C), which are destructive to the biology as well as a time consuming process. Thus, Phoenix will address a significant market need within the burgeoning ATMP industry. SH-SY5Y neuroblastoma cells were cultured in a stationary Phoenix for up to 5 days to assess cell viability and proliferation. The results show there is no significant difference in cell proliferation (∼5X growth on day 5) or viability (>90% viability on all days) when cultured in PhoenixTM and compared to a standard 5% CO2 incub...Continue Reading

References

Mar 8, 2005·The Journal of Reproduction and Development·Hiroshi IwayamaYutaka Fukui
Aug 30, 2011·European Journal of Health Law·A Mahalatchimy
Jun 21, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Jacob LevronDavid Bider
Apr 4, 2015·Science·Steven A Rosenberg, Nicholas P Restifo
Nov 8, 2015·World Neurosurgery·Amin AdibiAlim Mitha
Jan 6, 2017·The World Journal of Men's Health·Amanda B Reed-Maldonado, Tom F Lue
Jul 13, 2018·Stem Cell Research & Therapy·Lara LopesAlan Dardik
Jan 1, 2019·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Luke LawWenchun Qu
May 18, 2019·Stem Cells Translational Medicine·Cesario V Borlongan
Dec 1, 2019·Journal of Translational Medicine·Soukaina BahsounElizabeth C Akam

❮ Previous
Next ❯

Software Mentioned

Phoenix

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Human Gene Therapy. Clinical Development
Zuzana KočíŠárka Kubinová
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
C WalterH von der Leyen
BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
John SpoorsSheena Vithlani
© 2021 Meta ULC. All rights reserved